Literature DB >> 32477684

The Impact of Medical Big Data Anonymization on Early Acute Kidney Injury Risk Prediction.

Xing Song1, Lemuel R Waitman1, Yong Hu2, Bo Luo3, Fengjun Li3, Mei Liu1.   

Abstract

Artificial intelligence enabled medical big data analysis has the potential to revolutionize medical practice from diagnosis and prediction of complex diseases to making recommendations and resource allocation decisions in an evidence-based manner. However, big data comes with big disclosure risks. To preserve privacy, excessive data anonymization is often necessary, leading to significant loss of data utility. In this paper, we develop a systematic data scrubbing procedure for large datasets when key variables are uncertain for re-identification risk assessment and assess the trade-off between anonymization of electronic health record data for sharing in support of open science and performance of machine learning models for early acute kidney injury risk prediction using the data. Results demonstrate that our proposed data scrubbing procedure can maintain good feature diversity and moderate data utility but raises concerns regarding its impact on knowledge discovery capability. ©2020 AMIA - All rights reserved.

Entities:  

Keywords:  Acute Kidney Injury; Data Anonymization; Data utility; Medical Big Data; Re-identification risk

Year:  2020        PMID: 32477684      PMCID: PMC7233037     

Source DB:  PubMed          Journal:  AMIA Jt Summits Transl Sci Proc


  2 in total

1.  Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2.

Authors:  T Christopher Mast; David Heyman; Erik Dasbach; Craig Roberts; Michelle G Goveia; Lyn Finelli
Journal:  Vaccine X       Date:  2021-01-09

2.  Privacy of Study Participants in Open-access Health and Demographic Surveillance System Data: Requirements Analysis for Data Anonymization.

Authors:  Matthias Templ; Chifundo Kanjala; Inken Siems
Journal:  JMIR Public Health Surveill       Date:  2022-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.